The DIA QPPV Global Forum is the high-level platform to discuss and shape the evolution of the QPPV role. Get a strategic overview and exchange learnings with key executives from industry, healthcare organizations and senior regulators.

Hear directly from:

• Vicki Edwards (AbbVie) and Elspeth McIntosh (Castle Pharmacovigilance Limited): The evolution and challenges of the QPPV role
• Anja Van Haren (MEB), Magnus Ysander (AstraZeneca) and Phil Tregunno (MHRA): Learnings from the Covid-19 pandemic
• Shahinaz Badr (Newbridge Pharmaceuticals), Willemijn van der Spuij (Bristol-Myers Squibb) and Gillian Winstanley (Amgen): Updates on QPPV requirements and expectations in non-EU countries